drugset / Trial / NCT04664803

Safety and Efficacy of Cefecin Tab. in Patients With Acute Sinusitis

NCT04664803

Phase 4 Terminated 284 enrolled Korea United Pharm. Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a multi-center, double-blind, randomized, active controlled, parallel group phase 4 clinical trial to re-confirm the efficacy and safety of cefetamet pivoxil formulation in sinusitis patients

Timeline

Start
2015-08-31
Primary completion
2019-06-28
Completion
2019-08-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator cefdinir Other / unclassified 100 mg
Subject cefetamet pivoxil Unknown 500 mg

Indications